Efficacy and safety of thalidomide for recurrent aphthous stomatitis: a systematic review and meta-analysis of randomized controlled trials

Yang Jian,Fuqin Wang,Minru Zhao,Xianru Han,Xiaoyu Wang
DOI: https://doi.org/10.1186/s12903-024-04923-1
2024-09-29
BMC Oral Health
Abstract:Recurrent aphthous stomatitis (RAS) is considered as the most common oral mucosal lesion affecting up to 25% of people worldwide. Thalidomide has been reported for the treatment of RAS, but the evidence has not been systematically evaluated. We first systematically reviewed the efficacy and safety of thalidomide for the treatment of RAS.
dentistry, oral surgery & medicine
What problem does this paper attempt to address?